Vir Biotechnology, Inc.VIRNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank50
3Y CAGR-12.2%
5Y CAGR-24.5%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-12.2%/yr
Annual compound
5Y CAGR
-24.5%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.09 | +25.6% |
| 2024 | 0.87 | +2.5% |
| 2023 | 0.85 | -47.5% |
| 2022 | 1.62 | -57.5% |
| 2021 | 3.80 | -14.7% |
| 2020 | 4.45 | +39.4% |
| 2019 | 3.19 | +142.1% |
| 2018 | -7.58 | -434.5% |
| 2017 | -1.42 | - |